NCT03493698

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

A Phase 1, Open-label, Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: F-star Therapeutics, Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a single center, open-label, fixed sequence study to investigate the effect of multiple oral dosing of Inarigivir Soproxil and a single oral dose of Midazolam in Healthy Subjects

Conditions

• Drug Interaction Potentiation

Interventions

Type	Name	Description
DRUG	Midazolam	Midazolam
DRUG	Inarigivir	Inarigivir

Timeline

• Start date: 2018-05-07
• Primary completion: 2018-08-27
• Completion: 2018-08-27
• First posted: 2018-04-10
• Last updated: 2020-10-08
• Results posted: 2020-10-08

Locations

1 site across 1 country: Netherlands